MISSION STATEMENT:
The Mission of the Section of Neuro-Oncology at the University of Wisconsin School of Medicine and Public Health is to promote the health of patients with oncology-related neurological disorders. We are a group of individuals with diverse interests and the common goal to maintain excellence in clinical care, education, and research.
Providers
Sponsor: CNS Pharmaceuticals Award: CNS-201 PI: Bhatia, Ankush 23/09/2022 - 31/12/2040 |
| ONC201 vs placebo in H3K27M-mutant diffuse midline glioma Sponsor: Chimerix, Inc. Award: ONC201-108 PI: Bhatia, Ankush 18/04/2023 - 31/12/2040 |
Sponsor: Imvax Inc. Award: 14379-201 PI: Bhatia, Ankush 31/05/2023 - 31/12/2099 |
| Lu177-DOTATATE in newly diagnosed and recurrent glioblastoma: Phase 1 Study Sponsor: Novartis Pharamaceuticals KK Award: AAA601A52101 PI: Bhatia, Ankush 01/10/2023 - 02/08/2025 |
| Pilot Study investigating the role of FAPI in glioma Sponsor: Radiology R&D/SOFIE Pharma Award: PI: - |
| Phase 3 Study randomizing patients to IV Berubicin vs PO Lomustine in 1st recurrent GBM Sponsor: Worldwide pharmaceuticals Award: PI: Bhatia, Ankush - |
| Phase 2 Study combining temozolomide with lomustine in MGMT Methylated GBM Sponsor: NRG Oncology (Cooperative Group) Award: PI: Bhatia, Ankush - |
| Phase 2 study combining Bevacizumab with Pulsed Reduced Dose Rate Radiotherapy in recurrent GBM Sponsor: Merck Award: PI: Bhatia, Ankush - |
| A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma Sponsor: Imvax Award: PI: Bhatia, Ankush - |
No Publications Found
